Features of treatment of type 2 diabetes mellitus in patients with concomitant pathology
Cardiovascular morbidity is widely spread in patients<sup> </sup>with type 2 diabetes mellitus. Cardiovascular mortality risk in patients with type 2 diabetes mellitus is twice to six times as high as in patients without diabetes. The incidence of macrovascular complications, such<sup> </sup>as strokes and peripheral arterial disease is very high, and the cardiovascular events associated with type 2 diabetes are the major cause of mortality in these patients. This article reviews the efficacy and safety of various antidiabetic drugs in patients with concomitant diseases, and regards diabetes management in elderly population. The available evidence on treatment of elder adults with type 2 diabetes and<sup> </sup>concomitant diseases is discussed, and<sup> </sup>a general approach to therapy is suggested.